Sientra, Inc. ( SIEN) Stock. Should you Buy or Sell? $ 0.64
0.02 (3.76 %)
Sientra, Inc. Analysis
Updated on 10-09-2022| Symbol | SIEN |
| Price | $0.64 |
| Beta | 1.936 |
| Volume Avg. | $805.95 thousand |
| Market Cap | $40.18 M |
| 52 Week Range | $0.6 - $6.36 |
Sientra, Inc. opened the day at $0.64 which is +'3.76 % on yesterday's close. Sientra, Inc. has a 52 week high of $6.36 and 52 week low of $0.6, which is a difference of $5.76. We like to see positive, upward trending shares, preferably with momentum. Market capitalization is $40.18 M and total net profit is $80683000 which means the company is trading at 0.50 times profit to market capitalization. Theoretically, if you were to buy Sientra, Inc. for $40.18 M, it would take 15 years to get your money back. Sientra, Inc. are in the Medical Devices space which will have a sweet spot and industry standard for net profit multiples.
Price Chart
Financials
Sientra, Inc. Stock Forecast - Is Sientra, Inc. a Buy or Sell?
| DCF Score | Strong Buy | |
| ROE Score | Strong Sell | |
| ROA Score | Sell | |
| DE Score | Strong Buy | |
| PE Score | Sell | |
| PB Score | Strong Buy | |
| Overall Recommendation | Buy |
Growth and Value
| PE Ratio | -1.670 |
| Dividend Yiel | 0.000 |
| Net Profit Margin | -0.282 |
Valuing Sientra, Inc.
| Price Book Value Ratio | 4.625 | Price To Book Ratio | 4.625 |
| Price To Sales Ratio | 0.471 | Price Earnings Ratio | -1.670 |
How liquid is Sientra, Inc.
| Current Ratio | 1.398 |
| Quick Ratio | 0.726 |
Debt
| Debt Ratio | 0.951 | Debt Equity Ratio | 19.208 |
| Long Term Debt To Capitalization | 0.891 | Total Debt To Capitalization | 0.903 |
Latest news about Sientra, Inc.
Sientra, Inc. (NASDAQ:SIEN ) Q2 2022 Earnings Conference Call August 11, 2022 4:30 PM ET Company Participants Oliver Bennett - Senior Vice President, General Counsel & Chief Compliance Officer Ron Menezes - President & Chief Executive Officer Andy Schmidt - Chief Financial Officer Conference Call Participants Alex Nowak - Craig-Hallum Brandon Vazquez - William Blair Jon Block - Stifel Chris Cooley - Stephens Kyle Bauser - Lake Street Capital Markets Operator Welcome to the Sientra's Earnings Conference Call. My name is Hilda, and I will be your operator for today.
Although the general rule of thumb is to avoid equities with heavy short interest, the new normal has brought with it new paradigms. One of these fresh approaches urges speculators to acquire short-squeeze stocks in an effort to move the equities higher, forcing the bears to cover their short positions.
Here's what you need to know about buying penny stocks on August 8th The post Penny Stocks to Buy on August 8th? 3 to Watch appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.
SANTA BARBARA, Calif., May 18, 2022 (GLOBE NEWSWIRE) -- Sientra, Inc. (NASDAQ: SIEN) (“Sientra” or the “Company”), announced today its participation at the Virtual 19 th Annual Craig-Hallum Institutional Investor Conference, which takes place June 1 st , 2022.
Sientra, Inc. (NASDAQ:SIEN ) Q1 2022 Earnings Conference Call May 12, 2022 4:30 PM ET Company Participants Oliver Bennett - Senior Vice President, General Counsel & Chief Compliance Officer Ron Menezes - President & Chief Executive Officer Andy Schmidt - Chief Financial Officer Conference Call Participants Margaret Kaczor - William Blair Jason Kreyer - Craig-Hallum Jon Block - Stifel Chris Cooley - Stephens Kyle Bauser - Colliers International Anthony Vendetti - Maxim Group Operator Good day and welcome to this Sientra, Inc. First Quarter 2022 Earnings Conference Call. All participants will be in listen only mode.
About Sientra, Inc.
Description :
Sientra, Inc., a medical aesthetics company, develops and sells medical aesthetics products in the United States and internationally. It offers silicone gel breast implants for use in breast augmentation and breast reconstruction procedures; breast tissue expanders; and scar management products under the Sientra Round, Sientra Teardrop, AlloX2, Dermaspan, Softspan, and BIOCORNEUM brand names. The company also provides body contouring products; facial and nasal implants; saline filled sizers. It serves to hospitals, surgery centers, plastic surgeons, dermatologists and other specialties. The company was formerly known as Juliet Medical, Inc. and changed its name to Sientra, Inc. in April 2007. Sientra, Inc. was incorporated in 2003 and is headquartered in Santa Barbara, California.
